Stromal Interaction Molecule 1 Antibody (YA2092)
(Synonyms: GOK; TAM; TAM1; IMD10; STRMK; D11S4896E)Stromal Interaction Molecule 1 Antibody (YA2092) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Stromal Interaction Molecule 1.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
|---|---|
| Dilution Ratio | 1:500-1:1000 |
Product Details
Stromal Interaction Molecule 1 Antibody (YA2092) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Stromal Interaction Molecule 1.
-
Host Rabbit
-
Clonality Recombinant,Monoclonal
-
Species ReactivityHuman, Mouse, Rat
-
Observed Molecular WeightObserved band size: 77 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 77 kDa
Entrez Gene: 6786 Human ; 20866 Mouse ; 361618 Rat
SwissProt: Q13586 Human ; P70302 Mouse ; P84903 Rat
OMIM: 612783 Human
A synthetic peptide of human Stromal interaction molecule 1 aa199-212.
Endogenous
Affinity Purified
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Liquid
-
Formulation
Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% Sodium azide and 0.05% BSA
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
Stromal Interaction Molecule 1 acts as a Ca(2+) sensor that gates two major inward rectifying Ca(2+) channels at the plasma membrane: Ca(2+) release-activated Ca(2+) (CRAC) channels and arachidonate-regulated Ca(2+)-selective (ARC) channels. Plays a role in mediating store-operated Ca(2+) entry (SOCE), a Ca(2+) influx following depletion of intracellular Ca(2+) stores. Upon Ca(2+) depletion, translocates from the endoplasmic reticulum to the plasma membrane where it activates CRAC channel pore-forming subunits ORA1, ORA2 and ORAI3 to generate sustained and oscillatory Ca(2+) entry. Involved in enamel formation[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21].
-
Subcellular Localization
Cell membrane; Single-pass type I membrane protein; Endoplasmic reticulum membrane; Single-pass type I membrane protein; Cytoplasm, cytoskeleton; Sarcoplasmic reticulum
-
Expression
Tissue_specificity:It is widely expressed in a variety of primary human cells and tumor cell lines. -
Isoforms & Post-Translational Modification
Q13586 has 2 isomers: Q13586-1: 77423 Da (predicted); Q13586-2: 62133 Da (predicted).
Glycosylation is required for cell surface expression;Phosphorylated predominantly on Ser residues -
Subunit
Monomer in the presence of Ca(2+); it oligomerizes in absence of Ca(2+) (PubMed:18854159). Forms homooligomers and heterooligomers with STIM2 (PubMed:11463338, PubMed:11983428, PubMed:18854159, PubMed:22451904, PubMed:24069340, PubMed:24351972). Interacts with pore-forming subunits of CRAC channels, ORAI1, ORAI2 and ORAI3; this interaction is potentiated upon Ca(2+) store depletion (PubMed:19706554, PubMed:32415068). Interacts (via the transmembrane region and the SOAR/CAD domain) with SPPL3; the interaction promotes the binding of STIM1 to ORAI1 (PubMed:25384971). Interacts (via the SOAR/CAD domain) witH2O2AI1 (PubMed:17905723, PubMed:19182790, PubMed:19249086, PubMed:24351972, PubMed:27185316, PubMed:28219928, PubMed:30481768). Interacts with MAPRE1; probably required for targeting to the growing microtubule plus ends (PubMed:19632184). Interacts with CRACR2A/EFCAB4B; the interaction is direct and takes place in absence of Ca(2+) (PubMed:20418871). Forms a complex with CRACR2A/EFCAB4B and ORAI1 at low concentration of Ca(2+), the complex dissociates at elevated Ca(2+) concentrations (PubMed:20418871). Interacts with SARAF, promoting a slow inactivation of STIM1-dependent SOCE activity, possibly by facilitating the deoligomerization of STIM1 (PubMed:22464749, PubMed:30481768). Interacts with EFHB; the interaction takes place upon Ca(2+)-store depletion and inhibits the association with SARAF (PubMed:30481768). Interacts with ASPH (isoform 8) (PubMed:22586105). Interacts with SLC35G1; intracellular Ca(2+)-dependent. May interact with ATP1A1, ATP2A2, ATP2B1, ATP2B4, KPNB1 and XPO1; tH2O2gh SLC35G1 (PubMed:22084111). Interacts with TMEM203 (PubMed:25996873). Interacts with STIMATE, promoting STIM1 conformational switch (PubMed:26322679). Interacts with TMEM178A (By similarity). Interacts with CASQ1 (via C-terminal end and preferentially with the monomeric form); this interaction increases in response to a depletion of intracellular Ca(2+), decreases both STIM1 aggregation and clustering, interaction of STIM1 witH2O2AI1 and store-operated Ca(2+) entry (SOCE) activity (PubMed:27185316). Interacts with ADCY8 (PubMed:22494970)
-
SwissProt ID
-
Synonyms
GOK; TAM; TAM1; IMD10; STRMK; D11S4896E
-
Research Field
Neuroscience
Documentation